NeuroPace Inc (NPCE) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19
	10-K	10-K	10-K	S-1/A
Revenue	45.5	45.2	41.1	37.0
Revenue growth	0.7%	9.8%	11.3%
Cost of goods sold	13.0	11.7	10.9
Gross profit	32.5	33.4	30.3	26.5
Gross margin	71.4%	74.0%	73.6%	71.6%

Operating expenses
Research and development	21.9	18.2	15.7	18.3
Selling, general and administrative	51.3	39.0	27.6	30.2
Total operating expenses	73.3	57.2	43.3	48.5
Loss from operations	-40.8	-23.7	-13.1	-22.0
Operating margin	-89.6%	-52.5%	-31.7%	-59.6%
Interest income	1.6	0.4	0.0	0.3
Interest expense	-7.5	-7.4	-11.5	-9.5
Other income (expense), net	-0.3	-5.4	0.2
Net loss	-47.1	-36.1	-24.3
Comprehensive loss	-47.9	-36.4	-24.2

Net loss per share attributable to common stockholders, basic	($1.91)	($2.17)	($117.85)	($148.44)
Net loss per share attributable to common stockholders, diluted	($1.91)	($2.17)	($117.85)	($148.44)

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic	24.6	16.6	0.2	201.9
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted	24.6	16.6	0.2